1. Trading Members are hereby informed that Natco Pharma Limited (Scrip code: 524816) has announced buyback of its fully paid-up equity shares of face value of Rs.2/- each from the Open Market through electronic trading mechanism of the Exchange. The Maximum Buyback Price would not exceed Rs.1000/- (Rupees One Thousand Only) per equity share payable in cash for an aggregate amount not exceeding Rs.250 Crores.
2. Proposed time table for buyback:
|
Date of Opening of the Buyback on BOLT
|
November 19, 2018
|
|
Last date for the Buyback
|
Earlier of:
(a) May 18, 2019 (i.e., 6 months from the date of the opening of the Buy-back); or
(b) when the Company completes the Buy-back by deploying the amount equivalent to the Maximum Buy-back Size; or
(c) at such earlier date as may be determined by the Board/or its duly authorized Buy-back committee, after giving notice of such earlier closure, subject to the Company having deployed an amount equivalent to the Minimum Buy-back Size (even if the Maximum Buy-back Size has not been reached or the Maximum Buy-back Shares have not been bought back), however, that all payment obligations relating to the shares bought back shall be completed before the last date for the Buy-back.
|
3. Broker Members for buyback:
The company has appointed the following BSE Trading Members through whom the purchases and settlement on account of the buyback would be made:
|
Name of the Member
|
Clearing No
|
|
Axis Capital Limited
|
6105
|
4. Details of Buyback orders on BOLT.
The Trading Members may note that the Equity Shares held in DEMAT form can be offered for Buyback to the Company in rolling settlement, as per details mentioned below:
Scrip Code No. : 524816
Market Lot : 1 Share
Scrip ID on BOLT System : NATCOPHARM*
5. Orders entered by Designated Buyback Member & Client Code is available in the Odd Lot order entry screen (Ctrl+F7) under ‘Grab’ tab -> Buy Odd Lot Bids.
6. Circuit Filters, Margins, Capital Adequacy Norms, Auction, Close out, Bad Delivery, Arbitration, etc. are applicable in case of buyback as in the case of the normal trading.
7. Institutional Investors are allowed to participate in the buyback.
8. The documents are available in Department of Corporate Services for inspection. In case of any queries /clarifications on the scheme of buyback, Trading Members may please contact the under mentioned persons:
· Manager to the Buyback:
Contact Person: Mr. Sagar Jatakiya
Axis Capital Limited
1st Floor, Axis House
C-2 Wadia International Centre,
P. B. Marg, Worli
Mumbai - 400 025,
Maharashtra, India
Tel.: +91 22 4325 2183
Fax: +91 22 4325 3000
Email: npl.buyback@axiscap.in
· At the Company :
Contact Person: Mr. M. Adinarayana (Compliance Officer And Investor Service Centre)
Natco Pharma Limited
Natco House, Road No. 2, Banjara Hills,
Hyderabad - 500 034,
Telangana, India
Tel.: +91 40 23547532
Fax: +91 40 23548243
Email: investors@natcopharma.co.in
· At the Exchange:
Clearing & Settlement Department -
Mr. Nilesh Shah/Ajay Darji - Extn: 022-2272-8704/8468 (For Clearing & Settlement)
Trading Department -
Trading Operations - Extn: 022-2272- 8436 (For Trading Related)
Help desk - Extn: 61363100 (Hunting) (For BOLT System)
Listing Operations Department –
Mr. Raghavendra Bhat - Extn: 022-2272-8915 (For General Queries)
Rupal Khandelwal
Manager
November 16, 2018 |